IPQ Inside the global regulatory dialogue

FDA’s OPQ Adapts ANDA Risk-Ranking Model for Drug Substance Reviews

Feb 19th, 2016

Please Log in to print the full article

Starting Materials Examined First Johnson explained how her division adapted the severity, detectability, and occurrence components of the Failure Modes, Effects, and Criticality Analysis (FMECA) model to work with the API review process.  She also...

You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.

©2021 IPQ Publications